Evidence map›Paper›PMID 39087954›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Dendritic Cell Plasticity, Radiation, and Newton's Third Law.

Pawel Kalinski, Shipra Gandhi, Kathleen M Kokolus

Abstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pawel KalinskiDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0001-7025-3562
Shipra GandhiDepartment of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0003-3506-0284
Kathleen M KokolusDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0002-9088-5409

Funding

RPCI-UPCI Ovarian Cancer SPOREP50CA159981 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MOYSICH, KIRSTEN B., ODUNSI, KUNLE · 2013 to 2025
$19.6M
Targeting the Chemokine System to Sensitize Tumors to ImmunotherapyP01CA234212 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI KALINSKI, PAWEL · 2020 to 2024
$10.1M
Identifying the role of interferon and interferon-regulated chemokines in stress-induced immunosuppression in triple negative breast cancerR03TR004607 · NCATS · ROSWELL PARK CANCER INSTITUTE CORP · PI GANDHI, SHIPRA · 2023 to 2023
$174k
National Cancer Institute (NCI) P01CA234212NCATS NIH HHS R03 TR004607NCI NIH HHS P01 CA234212NCI NIH HHS P50 CA159981
6 · The paper itself

Abstract

Regulatory T cells protect damaged tissues but can undermine the effects of cancer treatments, including radiotherapy (RTx). Intratumoral immunostimulatory dendritic cells (type 1 conventional dendritic cells) respond to RTx with the production of regulatory T cell-attracting MDC/CCL22, undermining RTx effects. That effect can be reversed by EGFR-targeted IFNα, highlighting cDC1 plasticity and relevance as therapeutic targets. See related article by Bugno et al., p. 4450.

Indexed as

Cell PlasticityDendritic CellsNeoplasmsAnimalsHumansT-Lymphocytes, Regulatory

Identifiers

PMID39087954
PMCPMC11446472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.